None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with a confirmed diagnosis of Parkinson’s disease based on the clinical diagnostic criteria of the Movement Disorder Society (MDS) 2. Classified as Hoehn and Yahr stages 1–3, and capable of independent ambulation
Exclusion criteria
Exclusion criteria: 1. Patients diagnosed with dementia or severe depression (MoCA = 24) and currently under treatment 2. Patients with orthopedic conditions, such as arthritis or spinal disorders 3. Patients with a history of stroke or peripheral nerve and muscle disorders 4. Patients with severe visual or hearing impairments that prohibit the use of a VR headset 5. Patients deemed by the investigator to be at high risk of falls during VR-based table tennis exercises 6. Patients exhibiting moderate or higher levels of motion sickness symptoms on the Virtual Reality Sickness Questionnaire (VRSQ)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome variable will be assessed using the Movement Disorder Society–Unified Parkinson’s Disease Rating Scale Part 3 (MDS-UPDRS Part 3). Changes in motor symptom scores before and after the intervention will be measured to evaluate the effectiveness of the intervention. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary outcome variable will be measured using MDS-UPDRS Part 2, which evaluates changes in activities of daily living. Pre- and post-intervention score differences will be analyzed to assess the intervention's impact on patients’ functional abilities in daily life.;The secondary outcome variable will be measured using MDS-UPDRS Part 4, which evaluates complications of therapy, including dyskinesias and motor fluctuations. Differences between pre- and post-intervention scores will be analyzed to assess the impact of the intervention on treatment-related side effects.;Parkinson’s Disease Questionnaire-8 (PDQ-8) will be administered to assess changes in health-related quality of life. Pre- and post-intervention total scores will be compared to evaluate the impact of the intervention on patients’ perceived quality of life.;Timed Up and Go test (TUG) will be used to measure changes in gait and functional mobility. The time required for the patient to stand up from a chair, walk 3 meters, turn around, return, and sit down will be recorded. Differences between pre- and post-intervention times will be analyzed to assess improvements in mobility. | — |
Countries
Korea, Republic of
Contacts
Inje University Haeundae Paik Hospital